EN
HI
Summary
As of 3 Nov, 2026, Kilitch Drugs (India) stock price is ₹205.72. During the trading session, the stock has moved between an intraday low of ₹199.63 and an intraday high of ₹215.51. Over the last 52 weeks, Kilitch Drugs (India) has traded between ₹196.10 and ₹267.90.
The stock has recorded a trading volume of 49,823 shares,. Its Average Traded Price (ATP) is ₹206.35, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 803 @ ₹205.72.
Kilitch Drugs (India) has an upper circuit limit of ₹241.58 and a lower circuit limit of ₹161.06. The total value traded stands at ₹1.03 CR, and the delivery percentage for the day is 41.31%.
The stock is currently traded with a market lot size of 1. Kilitch Drugs (India) also offers a dividend yield of 0%.
Kilitch Drugs (India) Share Price Chart
Kilitch Drugs (India) Share Key Metrics
Volume
49823.00
Market Cap
719.23 CR
LTQ@LTP
803@205.72
ATP
206.35
Var Margin
23.03 %
Circuit Range
161.06-241.58
Delivery %
41.31 %
Value
1.03 CR
ASM/GSM
No
Market Lot
1
Kilitch Drugs (India) Fundamentals
P/E Ratio
23.38
P/B Ratio
2.5
Div. Yield
0
Sector P/E
39.15
Sector P/B
3.23
Sec. Div. Yield
0.54
Kilitch Drugs (India) Resistance and Support
Pivot 204.6
Resistance
First Resistance
208.95
Second Resistance
216.59
Third Resistance
220.94
Support
First Support
196.96
Second Support
192.61
Third Support
184.97
Kilitch Drugs (India) Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Nov 02 2026 | 201.81 | 205.72 | 2.19% | 215.51 | 199.63 |
| Fri Oct 30 2026 | 211.44 | 201.32 | -3.73% | 212.24 | 200.25 |
| Thu Oct 29 2026 | 210.19 | 209.13 | -2.72% | 218.27 | 207 |
Kilitch Drugs (India) Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-15 | Audited Results |
| 2026-02-11 | Quarterly Results & Bonus issue |
| 2025-11-13 | Quarterly Results |
| 2025-05-19 | Audited Results |
| 2025-02-11 | Quarterly Results |
| 2024-11-12 | Quarterly Results |
| 2024-08-08 | Quarterly Results |
Kilitch Drugs (India) News
Kilitch Drugs India Ltd - 524500 - Board Meeting Intimation for Consider And Approval Of Unaudited Standalone And Consolidated Financials Results For The Quarter And Half Year Ended 30Th September, 2026
Kilitch Drugs board to meet on 6 Nov 2026 for financial results.
Nov 02 2026 16:20:29
Kilitch Drugs India Ltd - 524500 - Notice Of EGM
Kilitch Drugs has scheduled an EGM on 16 November 2026 to approve the divestment of its entire stake in Ethiopia-based subsidiary Kilitch Estro Biotech PLC for USD 12.85 million. The sale includes the conversion of Rs.57 crore outstanding debt into equity prior to completion.
Oct 23 2026 17:15:17
Read More
Kilitch Drugs (India) Management
| Name | Position |
|---|---|
| Pushpa Nyoupane | Company Secretary & Compliance Officer |
| Mukund P Mehta | Managing Director |
Kilitch Drugs (India) Similar Stocks
Shree Ganesh Remedies Ltd.
598.85
-18.40 (2.98%)
Albert David Ltd.
768.45
5.65 (0.74%)
Gaudium IVF and Women Health Ltd.
105.64
-0.22 (0.21%)
Zim Laboratories Ltd.
134.77
-1.52 (1.12%)
Hexagon Nutrition Ltd.
58.14
4.03 (7.45%)
Valiant Laboratories Ltd.
125.84
-2.56 (1.99%)
Amanta Healthcare Ltd.
163.30
-0.26 (0.16%)
Osel Devices Ltd.
331.10
-4.40 (1.31%)
Wanbury Ltd.
190.52
1.31 (0.69%)
Kilitch Drugs (India) FAQs
The Buying Price of Kilitch Drugs (India) share is 205.72 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Kilitch Drugs (India) stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Kilitch Drugs (India), choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Kilitch Drugs (India) shares is 23.38. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Kilitch Drugs (India) shares is 2.5. Useful to assess the stock's value relative to its book value.
To assess Kilitch Drugs (India)’s valuation compare Sector P/E, P/B which are 39.15 & 3.23 with sector averages, along with growth rates and financial metrics.
The Market Cap of Kilitch Drugs (India) is 719.23 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Kilitch Drugs (India) share price is 267.90 & 196.10. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Kilitch Drugs (India) belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in KILITCH
